Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
40.99 USD | -0.97% | +0.59% | +166.51% |
05-17 | Vera Therapeutics Insider Sold Shares Worth $1,304,435, According to a Recent SEC Filing | MT |
05-10 | Wedbush Adjusts Vera Therapeutics' PT to $32 From $34, Keeps Neutral Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+166.51% | 2.24B | |
+41.79% | 54.04B | |
-0.56% | 41.92B | |
+47.19% | 41.96B | |
-7.20% | 28.35B | |
+12.59% | 26.35B | |
-21.51% | 19B | |
+6.92% | 13B | |
+24.91% | 12.19B | |
+29.60% | 12.28B |
- Stock Market
- Equities
- VERA Stock
- News Vera Therapeutics, Inc.
- Raymond James Initiates Vera Therapeutics at Outperform Rating With $29 Price Target